This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP) After a recent decision by the FDA a better day could be… Read More »
Researchers at the University of Georgia have developed a microfluidic chip to isolate circulating tumor cells (CTCs) from blood samples. Unlike other devices, this new chip uses magnetic microbeads to strip all the cells from the blood, leaving only the CTCs, in a technique the researchers have called “integrated ferrohydrodynamic cell separation”. The device is… Read More »
CRISPR gene editing changes the sequence of DNACARLOS CLARIVAN/SCIENCE PHOTO LIBRARY By Michael Le Page A team has used CRISPR to make a record-breaking 13,200 changes to the DNA of a single human cell. The feat takes us a step closer to being able to thoroughly rewrite the genomes of our cells and other organisms. Half… Read More »
Turkey provides cutting-edge medical services, including stem cell transplants, to millions – including the refugees it hosts – said a Turkish professor of hematology. Fevzi Altuntaş told Anadolu Agency (AA) that Turkey emulated developed countries in the West in its drive to offer patients high-end medical services. Altuntaş, founder of Turkish cord blood and bone… Read More »
SAN FRANCISCO—Novartis’ first-ever CAR-T cell therapy may have been hamstrung by early manufacturing problems, but the company still figures it can build a cell and gene therapy platform strong enough to deliver success not only with Kymriah but also a full “game board” of treatments for many more diseases, its CEO said on Monday. During his first… Read More »